<img alt="" src="https://secure.soil5hear.com/223550.png" style="display:none;">
Skip to content

 

Screen Enrollment

 

 

Champions Oncology has created screens that enroll each month in either In vivo, Ex vivo or In vitro platforms. These screens allow for significant cost savings compared to running stand-alone studies as well as provide free access to Standard of Care drug response data and other characterization data for each model. Check back frequently to learn more about each screen and to enroll in any active screens.

Screen Closing_10 model SynScreen March 2024
Screen Enrollment 2024_NSCLS April
Screen Enrollment Round -Systemic AML In Vivo Screen April 2024
Screen Enrollment Round- TumorGraft3D 100 Model Screen May 2024